ZILA--test for oral cancer? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ZILA--test for oral cancer?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Julio P. Antelo who wrote (23)	6/13/1996 1:41:00 AM
From: Ivan Andrew	of 61

In the '95 annual report, ZILA was authorized to issue 50 Mil. shares. They had issued under 48.5 Mil., so I think that's where the 644,000 for CTM came from. And as to why CTM would have done this deal, I'm not sure they had a choice--ZILA already owned 2/3 of the shares. It seems the kind of thing that ZILA would hold as an option, but I'm guessing. My take is that with the extra 70-80% that ZILA will be keeping from sales of OraTest now that they are distributing it themselves (see post #18 of this thread), it made sense to trade the 5.5 Million now for _all_ of the revenues in the future. This is just an interpretation, but I took it as a positive sign. One person's take on things... -Ivan

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next